- Email: [email protected]
Mini-Pfannenstiel hysterectomy versus LAVH
Abstracts
abdomen was opened in layers with tissue-grasping forceps (not Babcock); the tubes were brought out and ligated. Excellent results were obtained. Conclusion. This modification gives as cosmetic, satisfactory results as laparoscopic tubectomy, minus the cost and complications associated with laparoscopy. The procedure is of special value in developing countries.
like appearance, but without synechiae, and easily visualized hysteroscopically. Conclusion. In this patient, tamoxifen therapy resulted in recurrent hyperplastic polyps after endometrial ablation. However, hydrothermablation with heated saline under direct visualization preserved the integrity of the endometrial cavity, allowing prompt recognition of symptomatic vaginal bleeding and adequate evaluation.
15. Mini-Pfannenstiel Hysterectomy versus LAVH VR Benadikar. Ichalkaranji, Maharashtra, India.
17. Double-Blind, Randomized, Comparative Trial of NovaSure Impedance-Controlled Endometrial Ablation System and ThermaChoice Balloon Ablation System
Objective. To compare mini-Pfannenstiel hysterectomy with LAVH. Measurements and Main Results. Mini-Pfannenstiel hysterectomy was performed in 250 women with AUB, chronic PID with adhesions, small myomas and ovarian masses, and endometrial hyperplasia. A small transverse incision of less than 5 cm was made at the pubic hairline. Almost all uteri and adnexa were removed, except large myomas and large ovarian masses. A self-retaining retractor could not be used because of lack of space. Instead in the author's modification, uterus and adnexa were taken out through the abdominal wall and the procedure was completed. The technique resulted in invisible scars. Conclusion. This technique has benefits of LAVH minus the complications and cost of LH. It is especially useful in developing countries.
MY Bongers, P Bourdrez, BWJ Mol. Saint Joseph Hospital, Mb Veldhoven, The Netherlands.
Objective. To assess amenorrhea and success rates of the NovaSure procedure in comparison with ThermaChoice balloon ablation in 120 premenopausal women with menorrhagia (PBLAC ___150). Measurements and Main Results. The NovaSure system consists of a 3-dimensional bipolar device and RF controller that enable endometrial ablation in 90 seconds without the need for endometrial pretreatment. ThermaChoice consists of a latex balloon with a thermistor inside. The PBLAC, FSH levels, and additionaJ surgical interventions were evaluated at 3, 6, and 12 months. Quality of life was assessed before the intervention and 2 days, 2 weeks, and 3, 6, and 12 months after ablation. At &month follow-up the NovaSure group reported an amenorrhea rate of 54%, compared with 8% in the ThermaChoice group. At 12 months, amenorrhea rates were 47% and 12%, respectively. No complications were associated with either procedure. Conclusion. Preliminary clinical results indicate that the NovaSure system is an effective and safe secondgeneration device yielding high amenorrhea and success rates.
16. Hysteroscopic Evaluation of Postablation Endometrial Cavity JM Berrnan. Wayne State University School of Medicine, Detroit, Michigan.
Objective. To describe the uterine cavity after endometrial ablation. Measurements and Main Results. A 45-year-old, G2P2 woman was successfully treated with endometrial ablation. Two years later she was diagnosed with breast cancer, which was treated with excision, radiation therapy, and tamoxifen. One month after starting tamoxifen she again experienced heavy vaginal bleeding. Hysteroscopy revealed a hyperplastic polyp, and after resection, the bleeding abated until 6 months later, when she again developed menometrorrhagia. Recurrent hyperplastic polyp was confirmed by sonohysterography and resected hysteroscopically. Of note, the uterine cavity was long and narrow with a tunnel-
18. Deflecting Sigmoid Adhesions, an Anatomic Cause of CPP and Irritable Bowel Syndrome BW Bost. St. Elizabeth Hospital, Beaumont, Texas.
Objective. To evaluate the possible relationship among deflecting sigmoid adhesions (DSA), CPE and gastrointestinal symptoms.
$6
abdomen was opened in layers with tissue-grasping forceps (not Babcock); the tubes were brought out and ligated. Excellent results were obtained. Conclusion. This modification gives as cosmetic, satisfactory results as laparoscopic tubectomy, minus the cost and complications associated with laparoscopy. The procedure is of special value in developing countries.
like appearance, but without synechiae, and easily visualized hysteroscopically. Conclusion. In this patient, tamoxifen therapy resulted in recurrent hyperplastic polyps after endometrial ablation. However, hydrothermablation with heated saline under direct visualization preserved the integrity of the endometrial cavity, allowing prompt recognition of symptomatic vaginal bleeding and adequate evaluation.
15. Mini-Pfannenstiel Hysterectomy versus LAVH VR Benadikar. Ichalkaranji, Maharashtra, India.
17. Double-Blind, Randomized, Comparative Trial of NovaSure Impedance-Controlled Endometrial Ablation System and ThermaChoice Balloon Ablation System
Objective. To compare mini-Pfannenstiel hysterectomy with LAVH. Measurements and Main Results. Mini-Pfannenstiel hysterectomy was performed in 250 women with AUB, chronic PID with adhesions, small myomas and ovarian masses, and endometrial hyperplasia. A small transverse incision of less than 5 cm was made at the pubic hairline. Almost all uteri and adnexa were removed, except large myomas and large ovarian masses. A self-retaining retractor could not be used because of lack of space. Instead in the author's modification, uterus and adnexa were taken out through the abdominal wall and the procedure was completed. The technique resulted in invisible scars. Conclusion. This technique has benefits of LAVH minus the complications and cost of LH. It is especially useful in developing countries.
MY Bongers, P Bourdrez, BWJ Mol. Saint Joseph Hospital, Mb Veldhoven, The Netherlands.
Objective. To assess amenorrhea and success rates of the NovaSure procedure in comparison with ThermaChoice balloon ablation in 120 premenopausal women with menorrhagia (PBLAC ___150). Measurements and Main Results. The NovaSure system consists of a 3-dimensional bipolar device and RF controller that enable endometrial ablation in 90 seconds without the need for endometrial pretreatment. ThermaChoice consists of a latex balloon with a thermistor inside. The PBLAC, FSH levels, and additionaJ surgical interventions were evaluated at 3, 6, and 12 months. Quality of life was assessed before the intervention and 2 days, 2 weeks, and 3, 6, and 12 months after ablation. At &month follow-up the NovaSure group reported an amenorrhea rate of 54%, compared with 8% in the ThermaChoice group. At 12 months, amenorrhea rates were 47% and 12%, respectively. No complications were associated with either procedure. Conclusion. Preliminary clinical results indicate that the NovaSure system is an effective and safe secondgeneration device yielding high amenorrhea and success rates.
16. Hysteroscopic Evaluation of Postablation Endometrial Cavity JM Berrnan. Wayne State University School of Medicine, Detroit, Michigan.
Objective. To describe the uterine cavity after endometrial ablation. Measurements and Main Results. A 45-year-old, G2P2 woman was successfully treated with endometrial ablation. Two years later she was diagnosed with breast cancer, which was treated with excision, radiation therapy, and tamoxifen. One month after starting tamoxifen she again experienced heavy vaginal bleeding. Hysteroscopy revealed a hyperplastic polyp, and after resection, the bleeding abated until 6 months later, when she again developed menometrorrhagia. Recurrent hyperplastic polyp was confirmed by sonohysterography and resected hysteroscopically. Of note, the uterine cavity was long and narrow with a tunnel-
18. Deflecting Sigmoid Adhesions, an Anatomic Cause of CPP and Irritable Bowel Syndrome BW Bost. St. Elizabeth Hospital, Beaumont, Texas.
Objective. To evaluate the possible relationship among deflecting sigmoid adhesions (DSA), CPE and gastrointestinal symptoms.
$6